Travel Vaccines Market Report 2020: Industry Trends, Size, Share, Growth and Forecast till 2025 - IMARC Group

According to IMARC Group’s recently published report titled “Travel Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the market to reach US$ 7.5 Billion by 2025, exhibiting a CAGR of 6.2% during 2020-2025.

Travel vaccines are immunization shots that travelers can get before traveling to other parts of the world where there is a high risk of developing certain diseases. These vaccines build immunity against viral and microbial invasions while improving the overall health of the individual. They introduce the disease-causing microbes into the bloodstream to help the human body develop antibodies to fight off the same, if exposed to in the future. These shots must be taken at least 4 to 6 weeks before traveling as this gives enough time for the immunization to start working efficiently.

Global Travel Vaccines Market Trends:

Rising occurrence of infectious and travel-related diseases such as Japanese encephalitis, diphtheria, meningitis and yellow fever is one of the major factors that are driving the growth of the market. In addition to this, owing to factors such as the rising globalization and reduced international airfares, there has been an increase in international tourism. Consequently, the sales of travel vaccines have also witnessed a significant rise across the globe. Apart from this, several combination vaccines are also available for travelers, which protect against more than one disease.

They are widely gaining popularity amongst the users as they reduce the number of vaccines required. Furthermore, government bodies in several countries are investing in promoting the use of these vaccines. For instance, the National Health Service (NHS) is providing several free travel vaccines for diseases such as cholera, polio, typhoid and hepatitis A in the United Kingdom to reduce the risk of these diseases being spread across the country.

Request For Free Sample Pdf Copy @ https://www.imarcgroup.com/travel-vaccines-market/requestsample

Note: As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Market Segmentation

Market Breakup by Composition

1. Mono Vaccines
2. Combination Vaccines

Market Breakup by Disease

1. Hepatitis A
2. DPT
3. Yellow Fever
4. Typhoid
5. Hepatitis B
6. Measles and Mumps
7. Rabies
8. Meningococcal
9. Varicella
10. Japanese Encepthalitis
11. Others

Market Breakup by Region

1. North America
2. Europe
3. Asia Pacific
4. Middle East and Africa
5. Latin America

View Report TOC, Figures and Tables: https://www.imarcgroup.com/travel-vaccines-market

Some of the major players operating in the industry include

Novartis AG ADR (NVS)
GlaxoSmithKline plc (GSK)
Sanofi S.A. (SAN)
Merck & Co. Inc. (MRK)
Pfizer (NYSE: PFE)
ALK-Abelló
Bavarian Nordic
Crucell N.V.
CSL Limited
MedImmune, LLC,
Altimmune
Abbott Laboratories
F. Hoffman-La Roche Ltd.

Browse related reports:

Diabetic Retinopathy Market: https://www.medgadget.com/2020/08/diabetic-retinopathy-market-size-share-industry-report-covid-19-impact-analysis-and-forecast-2020-2025-imarc-group.html

Mechanical Ventilators Market: https://www.medgadget.com/2020/08/mechanical-ventilators-market-2020-industry-overview-share-growth-trends-and-forecast-till-2025-imarc-group.html

Contact US: IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

This release was published on openPR.